Wolverine Trading’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.06M | Buy |
251,100
+37,900
| +18% | +$296K | ﹤0.01% | 2161 |
|
|
2025
Q2 | $1.79M | Buy |
213,200
+33,800
| +19% | +$245K | ﹤0.01% | 1792 |
|
|
2025
Q1 | $1.45M | Buy |
179,400
+84,500
| +89% | +$855K | ﹤0.01% | 1902 |
|
|
2024
Q4 | $884K | Buy |
94,900
+33,400
| +54% | +$322K | ﹤0.01% | 2783 |
|
|
2024
Q3 | $520K | Sell |
61,500
-14,200
| -19% | -$118K | ﹤0.01% | 3020 |
|
|
2024
Q2 | $740K | Sell |
75,700
-34,000
| -31% | -$415K | ﹤0.01% | 2470 |
|
|
2024
Q1 | $1.66M | Sell |
109,700
-37,000
| -25% | -$671K | ﹤0.01% | 1758 |
|
|
2023
Q4 | $3.16M | Buy |
146,700
+12,100
| +9% | +$223K | ﹤0.01% | 1370 |
|
|
2023
Q3 | $2.5M | Buy |
134,600
+40,000
| +42% | +$934K | ﹤0.01% | 1430 |
|
|
2023
Q2 | $2.39M | Sell |
94,600
-35,900
| -28% | -$904K | ﹤0.01% | 1375 |
|
|
2023
Q1 | $3.19M | Sell |
130,500
-25,400
| -16% | -$680K | ﹤0.01% | 1091 |
|
|
2022
Q4 | $3.69M | Buy |
+155,900
| New | +$4.2M | 0.01% | 1047 |
|
|
2022
Q2 | – | Sell |
-355,100
| Closed | -$25.9M | – | 5693 |
|
|
2022
Q1 | $25.9M | Sell |
355,100
-53,200
| -13% | -$3.83M | 0.03% | 349 |
|
|
2021
Q4 | $38.5M | Buy |
408,300
+61,300
| +18% | +$7.33M | 0.05% | 289 |
|
|
2021
Q3 | $43.7M | Sell |
347,000
-21,100
| -6% | -$3.07M | 0.05% | 266 |
|
|
2021
Q2 | $63.1M | Buy |
368,100
+77,800
| +27% | +$12.6M | 0.1% | 144 |
|
|
2021
Q1 | $50.7M | Buy |
290,300
+70,700
| +32% | +$16.4M | 0.08% | 165 |
|
|
2020
Q4 | $44.7M | Buy |
219,600
+61,400
| +39% | +$12.5M | 0.07% | 182 |
|
|
2020
Q3 | $34.4M | Sell |
158,200
-5,500
| -3% | -$1.16M | 0.08% | 159 |
|
|
2020
Q2 | $30.7M | Sell |
163,700
-7,900
| -5% | -$1.38M | 0.08% | 153 |
|
|
2020
Q1 | $28.1M | Buy |
171,600
+20,200
| +13% | +$2.35M | 0.08% | 153 |
|
|
2019
Q4 | $12.6M | Sell |
151,400
-9,200
| -6% | -$700K | 0.03% | 570 |
|
|
2019
Q3 | $10.7M | Buy |
160,600
+18,800
| +13% | +$1.24M | 0.03% | 497 |
|
|
2019
Q2 | $9.42M | Sell |
141,800
-21,500
| -13% | -$1.25M | 0.03% | 551 |
|
|
2019
Q1 | $9.08M | Buy |
163,300
+29,300
| +22% | +$1.79M | 0.03% | 539 |
|
|
2018
Q4 | $6.49M | Buy |
134,000
+63,800
| +91% | +$3.9M | 0.02% | 660 |
|
|
2018
Q3 | $6.06M | Buy |
70,200
+48,100
| +218% | +$3.43M | 0.01% | 850 |
|
|
2018
Q2 | $891K | Hold |
22,100
| – | – | ﹤0.01% | 2384 |
|
|
2018
Q1 | $891K | Buy |
+22,100
| New | +$834K | ﹤0.01% | 2384 |
|
|
2017
Q4 | – | Sell |
-27,500
| Closed | -$912K | – | 5460 |
|
|
2017
Q3 | $912K | Buy |
27,500
+6,800
| +33% | +$223K | ﹤0.01% | 1993 |
|
|
2017
Q2 | $730K | Buy |
20,700
+3,300
| +19% | +$96.2K | ﹤0.01% | 2051 |
|
|
2017
Q1 | $438K | Sell |
17,400
-2,400
| -12% | -$49.9K | ﹤0.01% | 2553 |
|
|
2016
Q4 | $327K | Buy |
19,800
+8,500
| +75% | +$144K | ﹤0.01% | 3158 |
|
|
2016
Q3 | $204K | Buy |
+11,300
| New | +$198K | ﹤0.01% | 3809 |
|
Other funds holding TDOC
Wolverine Trading's TDOC Position: Q3 2025 in Review
Wolverine Trading increased its Teladoc Health (TDOC) stake by 104% in Q3 2025, buying an estimated $96.5K and bringing the position to 24,209 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #4931.
Wolverine Trading first reported a position in TDOC in Q2 2017 and has held it in 28 quarters since. The position peaked at $15.3M in Q4 2020. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.
- Wolverine Trading held 24,209 shares of Teladoc Health worth $199K as of Q3 2025.
- Wolverine Trading bought 12,370 Teladoc Health shares in Q3 2025, an estimated $96.5K.
- Teladoc Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4931 holding.
- Wolverine Trading first reported a position in Teladoc Health in Q2 2017 and has held it in 28 quarters since.
- Wolverine Trading's Teladoc Health position peaked at $15.3M in Q4 2020.
- 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.